Earnings call transcript: ErreDue H1 2026 revenue doubles as energy transition starts

ErreDue’s H1 2026 revenue doubled year over year to EUR 14.2 million, while EBITDA rose 127% to EUR 4.11 million and its margin expanded to 28.9% from 25%. The company nevertheless reported a EUR 3.2 million net loss as it continued investing in capacity; it delivered five energy-transition plants and expects further deliveries in 2026–27. Management expects the new production facility to be completed by end-2026, while shares were reported unchanged at $11.3.

Analysis

The key underwriting question is whether H1 marks repeatable end-market demand or a policy-deadline-driven shipment cluster. A large share of generator sales came from energy transition, while production value includes work-in-progress and finished goods intended for later delivery. That makes order conversion, customer advances, and cash collected more informative than EBITDA growth alone. Higher inventory and capex also mean reported operating leverage may not translate quickly into free cash flow.

Near term, the market may reward proof of continued deliveries; over 1–3 months, watch H2 shipment cadence, backlog quality, and working-capital conversion. Over 6–18 months, completing and ramping the new facility could support growth, but the stated capacity target is not evidence of utilization or profitable demand. Hydrogen project economics remain exposed to subsidy timing, power prices, and customers’ ability to finance projects. The PIEL jewelry-brand return adds execution and management-focus risk rather than a demonstrated earnings driver.

Contrarian view: the headline growth may understate traditional-market recovery, but it may also overstate the durability of hydrogen demand if Italian PNRR timing pulled deliveries forward. Do not infer valuation upside from the article’s fair-value claim or inconsistent share-price references. The thesis improves with repeat orders, advances/cash receipts, and positive free cash flow; it weakens if deliveries slip, inventory rises faster than sales, or margins reverse.

Key Decisions for Investors

• Avoid chasing the earnings headline; treat RDUE as a conditional watchlist idea until the next report verifies order-to-delivery conversion and cash generation.
• For a potential long, require evidence over the next 1–3 months of H2 deliveries on schedule, stable EBITDA margins, and working capital not consuming a disproportionate share of operating earnings. No price target is supportable from the supplied information.
• Track quarterly backlog by end market, customer advances, receivables and inventory, operating cash flow/free cash flow, and facility completion/ramp. These are the key checks on whether growth is funded by customers or by the balance sheet.
• Falsify the growth thesis if PNRR-related demand proves to be pulled forward, planned 2026–27 shipments slip, or inventory and receivables rise without matching cash receipts. Also reassess if the new site’s completion or ramp is delayed.